IntraBio Inc. today announced that the European Commission granted marketing authorization to AQNEURSA® (levacetylleucine) for the treatment of neurological manifestations of Niemann-Pick Type C (NPC) ...
With billions of active users across TikTok, Instagram, YouTube and other social media platforms, cutting down on screen time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results